We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis (OXAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01678092
Recruitment Status : Completed
First Posted : September 3, 2012
Last Update Posted : November 26, 2015
Sponsor:
Information provided by (Responsible Party):
Kari Christine Nadeau, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2006
  Study Completion Date : December 2006